More options for adjuvant treatment of HER2-positive breast cancer: How to choose wisely? [electronic resource]
- International journal of cancer 12 2019
- 2901-2906 p. digital
Publication Type: Journal Article; Review
1097-0215
10.1002/ijc.32418 doi
Breast Neoplasms--drug therapy Chemotherapy, Adjuvant--methods Clinical Trials as Topic Evidence-Based Medicine Female Humans Molecular Targeted Therapy Neoplasm Staging Receptor, ErbB-2--metabolism Taxoids--therapeutic use